Publication Name	World Journal of Stem Cells
Manuscript ID	116824
Country	China

Category	Cell Biology
Manuscript Type	Correction
Article Title	Correction to “Synergism of calycosin and bone marrow-derived mesenchymal stem cells to combat podocyte apoptosis to alleviate adriamycin-induced focal segmental glomerulosclerosis”
Manuscript Source	Unsolicited Manuscript
All Author List	Qiong-Dan Hu, Rui-Zhi Tan, Yuan-Xia Zou, Jian-Chun Li, Jun-Ming Fan, Fahsai Kantawong and Li Wang
Funding Agency and Grant Number	Funding Agency Grant Number National Natural Science Foundation of China 82205002, 82104662 Science and Technology Project of Sichuan Province 2022YFS0621 Luzhou-Southwest Medical University Science and Technology Strategic Cooperation Project 2021LZXNYD-P04 Southwest Medical University of Affiliated Traditional Medicine Hospital Project 2022-CXTD-03
Corresponding Author	Li Wang, PhD, Professor, Senior Researcher, Research Center of Integrated Traditional Chinese and Western Medicine, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, No. 182 Chunhui Road, Longmatan District, Luzhou 646000, Sichuan Province, China. wangli111@swmu.edu.cn
Key Words	Correction; Calycosin; Mesenchymal stem cells; Focal segmental glomerulosclerosis; Apoptosis; Smad3
Core Tip	This is a correction to “Synergism of calycosin and bone marrow-derived mesenchymal stem cells to combat podocyte apoptosis to alleviate adriamycin-induced focal segmental glomerulosclerosis”. Upon re-examining our original data, we identified an error in the assembly of Figure 1F, where the glyceraldehyde-3-phosphate dehydrogenase loading control image was incorrectly placed due to a clerical oversight during figure preparation. As the corresponding author, I am submitting the corrected figure.
Citation	Hu QD, Tan RZ, Zou YX, Li JC, Fan JM, Kantawong F, Wang L. Correction to “Synergism of calycosin and bone marrow-derived mesenchymal stem cells to combat podocyte apoptosis to alleviate adriamycin-induced focal segmental glomerulosclerosis”. World J Stem Cells 2026; In press

Received	2025-11-21 05:31
Peer-Review Started	2025-11-25 03:39
First Decision by Editorial Office Director	2025-11-26 08:10
Return for Revision	2025-11-26 08:10
Revised	2025-12-01 08:03
Publication Fee Transferred	2025-12-03 09:20
Second Decision by Editor	2026-01-07 02:36
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2026-01-07 09:07
Articles in Press	2026-01-07 09:07
Edit the Manuscript by Language Editor
Typeset the Manuscript

ISSN	1948-0210 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com